Skip to main content

Ana Daniela Ulloa Navas

Institutions of which they are part

Predoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Ana Daniela Ulloa Navas

Institutions of which they are part

Predoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Laura Martin Fernandez

Laura Martin Fernandez

Postdoctoral researcher
Transfusional Medicine
Read more
Maria Dolores Castilllo Cejas

Maria Dolores Castilllo Cejas

Predoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Juan Luis Restrepo Vera

Juan Luis Restrepo Vera

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Read more
Fernanda Mucarzel Suarez-Arana

Fernanda Mucarzel Suarez-Arana

Research technician
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.